Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

Rationale & Objective: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes. This analysis explores the efficacy and safety of finerenone in Hispanic patients. Study Design: Post hoc analysis of the FIDELITY prespecified pooled a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sylvia E. Rosas, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco Jaramillo Munoz, Pablo Pergola, Guillermo E. Umpierrez, Andrea Scalise, Charlie Scott, Robert Lawatscheck, Amer Joseph, George L. Bakris
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-10-01
Edice:	Kidney Medicine
Témata:	Type 2 diabetes chronic kidney disease cardiorenal Hispanic patients finerenone nonsteroidal mineralocorticoid receptor antagonist
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S259005952300122X
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!